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SUMMARY
Variation in clinical accuracy of molecular diagnostic methods for cutaneous leishmaniasis (CL) is commonly observed
depending on the sample source, the method of DNA recovery and the molecular test. Few attempts have been made to
compare these variables. Two swab and aspirate samples from lesions of patients with suspectedCL (n= 105) were evaluated
alongside standard diagnosis by microscopic detection of amastigotes or culture of parasites from lesion material. Three
DNA extractionmethods were compared: Qiagen on swab and aspirate specimens, Isohelix on swabs and Boil/Spin of lesion
aspirates. Recovery ofLeishmaniaDNAwas evaluated for each sample type by real-time polymerase chain reaction detection
of parasitic 18S rDNA, and the diagnostic accuracy of the molecular method determined. Swab sampling combined with
Qiagen DNA extraction was the most eﬃcient recovery method for LeishmaniaDNA, and was the most sensitive (98%; 95%
CI: 91–100%) and speciﬁc (84%; 95% CI: 64–95%) approach. Aspirated material was less sensitive at 80% (95% CI: 70–88%)
and 61% (95% CI: 50–72%) when coupled to Qiagen or Boil-Spin DNA extraction, respectively. Swab sampling of lesions
was painless, simple to perform and coupled with standardized DNA extraction enhances the feasibility of molecular
diagnosis of CL.
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INTRODUCTION
Parasitic protozoans of the genus Leishmania can
cause cutaneous leishmaniasis (CL), a disease man-
ifested by dermal ulcers and sores. The diagnosis
of CL remains problematic as the clinical spectrum
is broad and may mimic that of other diseases in-
cluding leprosy, fungal infections, skin cancer,
tropical ulcers, mycobacterial ulcers and staphylo-
coccal infections (WHO expert committee 2010).
Pentavalent antimonial therapy requiring daily in-
jections for up to 20 days remains the mainstay of
treatment for CL in Latin America. Diﬀerentiation
of CL from other diseases and prevention of overuse
of these toxic drugs require diagnostic tests to be
highly speciﬁc. Sensitive diagnostics are also import-
ant because some species of Leishmania can cause
chronic dermal manifestations and mucosal involve-
ment, often characterized by scarcity of parasites at
the lesion site.
Routine diagnosis of CL is based on demonstration
of amastigotes by microscopic examination of the
scrapings of skin lesions and in vitro culture of
parasites from aspirate material (Faber et al. 2003).
Both of these methods require well trained and ex-
perienced personnel, laboratory support and quality
control programmes; although the speciﬁcity should
be 100% due to visualization of the parasite, the sen-
sitivity can be variable. We have found that the sen-
sitivity of the diagnostic algorithm can be increased
by 8–10% by the inclusion of parasite isolation
by culturing the lesion aspirates with microscopy
(based on routine diagnosis at the outpatient clinics
in Centro Internacional de Entrenamiento e
Investigaciones Médicas (CIDEIM). However, cul-
turing presents logistical constrains including cost,
availability of appropriate culture media, infrastruc-
ture, access to sterile facilities, time to result (which
can take up to 2 months) among others. Cultured
isolates present the opportunity to discriminate
the species of Leishmania using isoenzyme electro-
phoresis. In Colombia, more than 90% of CL cases
are caused by a species of the Leishmania (Viannia)
subgenus, of which >75% correspond to Leishmania
panamensis infections (Saravia et al. 1998).
Molecular methods have become attractive tools
for the diagnosis of CL as they can provide sensitive,
speciﬁc, rapid and reliable detection of parasites. Cur-
rently, these require highly experienced personnel
and well-equipped laboratories; however, eﬀorts are
being made to simplify these tools. Several molecular
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ampliﬁcation methods have been designed for the
diagnosis of CL (Ramirez et al. 2000; van der Meide
et al. 2008; Espinosa et al. 2009; Adams et al. 2010;
Miranda et al. 2012; Hu et al. 2012; Jara et al. 2013)
but few have been evaluated for diagnostic accuracy
and speciﬁcity in studies based on consecutive in-
clusion and assessment of patients with suspected
CL rather than known positive and negative cases
(Boggild et al. 2010; Jara et al. 2013). Diagnostic
accuracy of molecular assays can vary depending on
the sample used andmethod of DNA recovery as well
as the molecular target and protocol employed. Few
attempts have been made to compare the usefulness
of diﬀerent lesion sampling procedures for poly-
merase chain reaction (PCR) -based diagnosis of CL
(Matsumoto et al. 1999), supporting the use of non-
invasive methodologies such as ﬁlter paper imprints
of lesions (Mimori et al. 2002; Boggild et al. 2011).
However, thus far simultaneous comparison of DNA
recovery methodologies and sample source has not
been analysed for the deﬁnition of highly sensitive
molecular diagnostics for CL. Simple, non-invasive
sampling methods coupled to standardized DNA
extraction protocols would facilitate reliable diag-
nosis using molecular tools and obviate invasive and
painful sampling procedures such as skin biopsies.
This study is aimed to test non-invasive swab
sampling of lesions and conventional aspirate sam-
pling coupled with simple and standardized DNA
extraction methods as the basis for optimized sample
processing for molecular diagnosis of CL. Clinical
specimens were obtained from patients with lesions
compatible with suspicion of CL and the diagnostic
accuracy of the sample types by quantitative PCR
(qPCR) was compared with standard diagnostic
methods.
MATERIAL AND METHODS
Study design
This study was designed to evaluate the performance
of non-invasive lesion-sampling methodologies
coupled to standardized DNA extraction and molec-
ular ampliﬁcation ofLeishmania 18S rDNA as a diag-
nostic tool for CL. Based on an estimated prevalence
of 85% in the suspect population and an expected
sensitivity of >90% of the qPCR (van derMeide et al.
2008), a sample size of 96 patients with suspected CL
was calculated with a 6% margin of error.
The reference gold standard for parasitological
diagnosis of CL was deﬁned as microscopic detection
of intracellular amastigotes in Giemsa-stained lesion
smears and/or culture isolation of Leishmania
from lesion aspirates. Patients with parasitological
conﬁrmation of Leishmania infection were referred
for treatment according to the standard-of-care
therapeutic guidelines provided by the Colombian
Ministry of Health and Social Protection (First
line: Glucantime®, 20mg kg−1 weight for 20 days).
True and presumptive false positive patients were
deﬁned, respectively, as patients with positive refer-
ence standard diagnosis and positive PCR, and nega-
tive reference standard diagnosis with positive PCR.
Ethics and study population
This study was approved and monitored by the
institutional review board for ethical conduct of
research involving human subjects of the CIDEIM
in accordance with national (resolution 008430,
República de Colombia, Ministry of Health, 1993)
and international (Declaration of Helsinki and
amendments, World Medical Association, Seoul,
Korea, October 2008) guidelines. All individuals
voluntarily participated in the study and informed
consent was obtained from each participant. Patients
(aged 2–75 years) with clinical manifestations com-
patible with active CL were invited to participate.
Patients with suspected CL were deﬁned as patients
who resided in or had visited known CL endemic
areas during the 6 months prior to the onset of the
lesion and presented skin lesions clinically compat-
ible with CL that had been present for more than
2 weeks.
Sampling techniques for reference standard
diagnosis of CL
Two smears of the lesion scrapings for microscopic
evaluation and 4 lesion-aspirate samples were ob-
tained from each patient at the CIDEIM outpatient
clinics in Cali and Tumaco, Colombia. Culture of
lesion aspirates in Senekjie’s diphasic culture media
was performed for all patients; parasite growth was
evaluated for 1-month post-inoculation.
Experimental procedures
Two swab samples and two lesion aspirates were
taken for molecular diagnosis of CL (Fig. 1). Swab
samples were taken by gently rubbing over the ulcer
*10 times (Fig. 2) using commercially available
DNA collection swabs (Isohelix SK-1S). For non-
ulcerated lesions (nodules, papules or plaques), swab
samples were taken from the incision from which
lesion scrapings were obtained. Lesion aspirates were
obtained from the lesion border as per standard pro-
cedure (Figueroa et al. 2009). Samples obtained from
CIDEIM-Tumaco were refrigerated using cold
packs during transport to CIDEIM-Cali. Swab sam-
ples were stored at −20 °C; aspirate samples were
put into Qiagen lysis buﬀer AL1 and then stored at
−20 °C; all samples were processed for DNA extra-
ction within 5 days after the samples were taken.
DNA extractions. Qiagen DNeasy Blood & Tissue
Kit (Qiagen, USA) was used to extract DNA from 1
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swab and 1 aspirate sample. Isohelix DNA Isolation
Kit (Cell Projects™, Kent, UK) was used to extract
DNA from the second swab. A crude ‘Boil-Spin’
method was used for the second aspirate sample.
Swab and aspirate replicate samples from each patient
were randomly selected for diﬀerent extractionmeth-
odologies. Extractions using Qiagen and Isohelix kits
were performed according to manufacturers’ proto-
cols and resultant DNA eluted in 50 μL distilled
water. Boil-Spin was processed using a protocol ad-
apted from http://www.ﬁnddiagnostics.org/export/
sites/default/programs/hat-ond/docs/SOP_RIME_
LAMP_kit_template_23MAR12_ﬁnal.pdf); 40 μL
plasma (bovine) plus 60 μL distilled water was
added to 100 μL of the aspirate sample and incubated
at 90 °C for 10min. The sample was centrifuged for
3min at 14000 rpm to eliminate any debris. Two
hundred microlitres of the supernatant was removed
and used as template DNA. Extraction controls
(reagents without DNA sample) were included
during every DNA extraction to verify the absence
of contamination during the extraction process.
Molecular ampliﬁcation. qPCR was set up as fol-
lows: reactions were conducted in a total volume of
12·5 μL, containing 1·25 μL of the DNA sample,
6·25 μL PCR Mastermix (BioRad), 0·8 μM of each of
the two oligonucleotide primers designed to amplify
Leishmania 18S rDNA and 0·2 μM of the Leishmania
18S rDNA-speciﬁc FAM-labelled TaqMan probe
(van der Meide et al. 2008). qPCR was performed in
CIDEIM, Cali on a BioRad CFX96 platform as
follows: denaturation at 95 °C for 10min, followed by
35 cycles of denaturation at 95 °C for 15 s and ﬁnally
at 60 °C for 50 s including FAM detection.
For quantiﬁcation of parasite load in patient
samples, cycle threshold (Ct) values of the samples
were extrapolated to a standard curve. Comparisons
between experiments were made with a standard
curve for 18S rDNA ampliﬁcation of L. panamensis
(MHOM/PA/71/LS94) DNA ranging from 107 to
102 parasites mL−1 in 10-fold dilutions (6 indepen-
dent replicate experiments with a standard deviation
of <0·25% and r2 0·992) and an eﬃciency of reaction
of 101·81%. The baseline threshold was set at 125
in order to compare between diﬀerent experiments;
Ct valuewasmeasured for each sample and quantiﬁed
compared to the standard curve. A negative PCR
control and extraction controls were included in
each DNA extraction and PCR assay. All samples
were analysed double blind to microscopy and
culture results.
Fig. 1. Flow of samples in evaluation. Two lesion smears and 4 aspirates were obtained as part of the reference
diagnostic procedure (microscopy and culture). Two lesion swab samples and 2 aspirates were obtained for evaluation by
qPCR.
Fig. 2. Specimen collection by swab sampling of a
cutaneous ulcer of a patient with suspected CL.
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Species identiﬁcation: Strains were isolated cul-
turing the needle aspirates of cutaneous lesions and
typed by immunoreactivity with monoclonal anti-
bodies. Isoenzyme electrophoresis was performed to
identify the species for the strains not accurately
typed by reactivity to monoclonal antibodies (Pratt
and David, 1981; McMahon-Pratt et al. 1982;
Saravia et al. 1998).
Data analysis
Data were entered into EpiData and transferred to
STATA for analysis. The diagnostic accuracy of data,
including sensitivity and speciﬁcity, was calculated
for each sample type, and all calculations include
95% conﬁdence intervals (CI). The Kolmogorov–
Smirnov test was applied to determine parametric
or non-parametric distribution of quantitative data.
Kruskal–Wallis 1-way analysis of variance (ANOVA)
followed by Dunn’s multiple comparison test was
employed for group comparisons. Statistical sig-
niﬁcance was deﬁned as P<0·05. Data were analysed
using Prism 5 software (GraphPad Software, Inc., La
Jolla, CA).
Standards for Reporting of Diagnostic Accuracy
(STARD) guidelines. This study followed the
STARD guidelines (Bossuyt et al. 2003), including
blinding of index and reference diagnostic tests.
RESULTS
Patients
A total of 105 suspected patients with lesions com-
patible with CL were included in this prospective
study in two outpatient clinics: CIDEIM-Cali
(n = 33) and CIDEIM-Tumaco (N = 72). Charac-
teristics of all enrolled participants and species iden-
tity of parasites isolated are summarized in Table 1.
In all 90·5% (95 of 105) of patients presented with at
least 1 ulcerated lesion. CL was conﬁrmed in 76·2%
(n = 80) of the suspected patients by gold standard
diagnosis. Fifty-four out of 80 CL patients presented
with both positive lesion smear and aspirate cultures;
15 of 80 were only positive for lesion smears and 11 of
80 for culture.
Leishmania species. Parasites were isolated and
identiﬁed in 64% of the participants. At least 4 diﬀer-
entLeishmania species pertaining to both theViannia
and Leishmania subgenera caused infections in the
participating patient population. The vast majority
belonged to species of the Viannia subgenus with
L. panamensis predominating overall.
Diagnostic accuracy
The diagnostic accuracy of each sample type coupled
with the pre-deﬁned extraction methodology (Fig. 1)
was calculated separately against the reference stan-
dard diagnostic. Data are summarized in Table 2.
The highest diagnostic sensitivity of 98% (95% CI:
90·91–99·61%) and speciﬁcity of 84% (95% CI:
64–95·4%) were achieved with qPCR performed on
the swab samples coupled with Qiagen DNA extra-
ction. CI of sensitivity overlapped for the swab
samples extracted with both Qiagen and Isohelix
commercial kits, and CI of speciﬁcity overlapped for
all extraction methods and sample types (Fig. 3). Of
the 10 suspects presenting solely with non-ulcerated
lesions, 6 were diagnosed with CL by standard diag-
nostic procedures; the same 6 patients were also
positive for Leishmania by qPCR.
Quantiﬁcation. Parasite loads were estimated by
qPCR for all swab and aspirate samples coupled
with individual extraction methodologies (Fig. 1).
Table 1. Characteristics of patients with suspected
CL.
Characteristics n (%)
Subjects n= 105 (%)
Diagnosis
Cutaneous leishmaniasisa 80 (76·2)
Lesion smear positive only 15 (14·3)
Culture positive only 11 (10·5)
Lesion smearand Other
culture positive
54 (51·4)
Lesion smear and culture negative 25 (23·8)
Age, median (range), years 23 (3–71)
Gender, male (%) 78 (74·3)
Ethnic group, n (%)
Afro-Colombian 47 (44·84)
Mestizo 51 (47·2)
Indigenous 7 (6·5)
White 1 (0·9)
Lesions per subject, median (range) 1 (1–50)
Duration of older lesion, median
(range), monthsa
2 (0·2–240)
Lesion characteristics n= 204 (%)
Location of lesion; n (%)a
Upper limbs 65 (32)
Head and neck 39 (19·2)
Trunk 31 (15·3)
Lower limbs 68 (33·5)
Type of lesion; n (%)
Ulcer 149 (73)
Plaque 28 (13·8)
Other 27 (13·2)
Lesion area, median (range), cm2 7·28 (0·16–48·7)
Leishmania strains isolated n= 64 (%)
Species identiﬁcation
Leishmania (V) panamensis 51 (79·7)
Leishmania (V) braziliensis 8 (12·5)
Leishmania (V) guyanensis 3 (4·7)
Leishmania amazonensis 1 (1·6)
Leishmania mexicana complex 1 (1·6)
a One patient was diagnosed with mucocutaneous disease.
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Parasite burden in swab samples extracted with either
Qiagen or Isohelix commercial kits was equivalent
(Fig. 3A and B). No statistical diﬀerence was ob-
served in parasite numbers obtained from aspirate
samples extracted with either Qiagen or Boil-Spin
methods (Fig. 3A). Importantly, parasite loads quan-
tiﬁed from the aspirate material from true positive
patients were signiﬁcantly lower than those obtained
from the swab samples (Fig. 3A). Parasite burden in
samples from lesions from true and presumptive false
positive patients (n = 6) showed that the true positive
patients (Fig. 3A) have higher parasite loads com-
pared to putative false positive patients (Fig. 3B), i.e.
those only detected by qPCR.
DISCUSSION
Here we describe the sensitive diagnosis by qPCR
of CL using non-invasive swab samples from patients
with lesions compatible with suspicion of CL
coupled with standardized DNA extraction pro-
cedures. Swab samples from lesions coupled with
Qiagen extraction identiﬁed more patients than
aspirate samples from lesions coupled with Qiagen
extraction. Swab samples were essentially painless to
collect compared with lesion scrapings and required
less expertise than aspirates or scrapings of lesions.
Nevertheless, some challenges for swab sampling
should be considered including non-ulcerated lesions
such as nodules, plaques or papules, manifestations
that present in variable proportions in diﬀerent ende-
mic settings. For non-ulcerated presentations, either
an incision or scraping of the lesion should be per-
formed, ideally followed by swab sampling to access
the dermal tissue containing the parasites. Transport
of swab samples to reference laboratories for analysis,
by ordinary or expedited mail using conventional
cold packs allows diagnosis and species identiﬁcation
by molecular methods to be achieved, as required for
clinical and public health needs.
Overlapping CI for speciﬁcity of DNA extraction
methods and sample types suggest that the 18S
rDNA is an adequate target for ampliﬁcation to
detect Leishmania DNA from clinical samples.
The speciﬁcity of qPCR coupled with swab sampling
and Qiagen extraction in this consecutive group of
patients appeared somewhat low at 84% with wide CI
(95% CI: 64–95%). However, 5/6 putatively false
positive patients presented with at least 2 positive
molecular methods, supporting the interpretation
that the index test (qPCR) is more sensitive than the
reference test (microscopy and culture). Considering
Table 2 Diagnostic accuracy of swab and aspirate samples compared with the reference diagnostic standard
of microscopy and/or culture positive (TP, true positive; FP, false positive; FN, false negative; TN, true
negative; CI, conﬁdence interval)
Sample type TP FP FN TN Sensitivity (95% CI) Speciﬁcity (95% CI)
Swab-Qiagen 78 4 2 21 97·5% (CI 91·2–99·6%) 84% (CI 63·9–95·4%)
Swab-Isohelix 74 4 6 21 92·5% (CI 84·4–97·2%) 84% (CI 63·9–95·4%)
Aspirate-Qiagen 64 2 16 23 80% (CI 69·6–88·1%) 92% (CI 73·9–98·8%)
Aspirate-Boil/Spin 49 1 31 24 61·3% (CI 49·7–71·9%) 96% (CI 79·6–99·3%)
(A)
(B)
Fig. 3. Quantiﬁcation of parasite loads from lesion swabs
and aspirate samples. (A) True positive samples and (B)
false positive samples. Parasite number was calculated
from a deﬁned Ct threshold of 125 CTU and extrapolated
to a parasite DNA standard curve. Data represent
number of parasites per reaction (1·25 μL DNA from a
total of 50 μL of DNA extraction material) and expressed
as median values. Whiskers in box plots show minimum
and maximum values. Statistical signiﬁcance was
estimated using the Kruskal–Wallis 1-way ANOVA
followed by the Dunn’s test for multiple comparisons.
***: P<0·01. Qiagen and Isohelix: DNA extractions with
Qiagen and Isohelix commercial kits, respectively. B/S:
Boil-Spin.
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that the samples from the same individuals were
independently taken, presumably these samples rep-
resent true positive patients undetected by micro-
scopic detection of amastigotes in smears of lesion
scrapings and/or parasite isolation from lesion as-
pirates. Inclusion of clinical characteristics and epi-
demiological risk factors (Weigle et al. 1993), as well
as response to speciﬁc therapy in reﬁning the deﬁni-
tion of ‘true positives’ would probably diminish the
disparity in speciﬁcity of conventional parasitological
diagnosis and molecular diagnosis of CL.
Quantiﬁcation of parasite load showed that the
parasite burden in true positive patients (diagnosed
by the gold standard method and index test) is higher
than that of putative false positive patients (only
positive by the index test), supporting the likelihood
that these patients may not have been detected by
microscopy or culture due to the low number of para-
sites in the active lesion. Parasite loads quantiﬁed by
qPCR revealed that less parasite DNAwas recovered
from lesion aspirates compared to swab samples for
both the true positive and the false positive samples.
This is surprising considering that aspirate samples
for parasite isolation are taken from lesion borders
where parasites are thought to be more abundant.
This ﬁnding may reﬂect the greater eﬃciency of
recovery of tissue material containing parasitic DNA
by swab sampling or the greater quantity of parasite
DNA in the ulcerated zone of the lesion. Since the CI
of the swab sampling coupled to Qiagen or Isohelix
DNA extraction overlapped, further exploration of
the Isohelix extraction kit would be worthwhile,
considering the reduced cost (Isohelix extraction cost
two-thirds of the Qiagen extraction), time and tech-
nical requirements.
The feasibility of implementing molecular diag-
nosis of CL beyond well-equipped laboratories
requires reﬁnement of sample processing, DNA
extraction and the use of simpliﬁed molecular diag-
nostics. Here qPCR was used as a method to assess
Leishmania DNA recovery from cutaneous lesions
by diﬀerent sampling methodologies. The recently
developed, loop-mediated isothermal ampliﬁcation
(LAMP) is an example of a simpliﬁedmolecular diag-
nostic that can be performed within 40min at 65 °C,
and allows a visual read-out. LAMP is currently
under development for leishmaniasis and should
be evaluated for CL when available (Adams et al.
2010; http://www.ﬁnddiagnostics.org/programs/hat-
ond/leishmaniasis/lamp-for-leish.html). Alternative
qPCR strategies including multiplex reactions for
Leishmania detection at the species level, and diﬀer-
ential diagnosis of other infectious agents such as
non-tuberculousmycobacteria orSporothrix, causing
similar cutaneous ulcers, could be relevant for clinical
decision making. As qPCR detects active infection
due to the presence of parasitic DNA, it is worth
noting the potential to detect relapse and monitor
response to treatment.
Non-invasive swab sampling allows samples to be
collected in rural areas and transported to central
laboratory facilities where standardized ampliﬁcation
can be eﬃciently and reliably conducted. Coupling
non-invasive sampling to a sensitive and simple mol-
ecular diagnostic test provides feasible alternatives
for diagnostic challenges such as leishmaniasis in
children and complicated manifestations including
chronic ulcers and mucosal disease. Furthermore,
swab sampling provides storage ﬂexibility as samples
can be obtained and stored at ambient temperature or
4 °C, or preserved at −20 °C for longer periods of
time. Systematic evaluation of temperature stability
needs to be conducted under the conditions of
diﬀerent settings considering that ambient tempera-
ture and potentially humidity index could impact the
stability of the biological material for DNA ampliﬁ-
cation.
CONCLUSION
We have demonstrated the feasibility and diagnostic
accuracy of a non-invasive alternative to aspirates and
biopsies for CL lesion sampling when coupled with
standardized DNA extraction and molecular ampliﬁ-
cation methods. Swab samples are easy to collect,
painless for the patient, can be conveniently trans-
ported, obviate use of needles, and recovery of DNA
from swabs is superior to aspirate samples.We recom-
mend the validation of swab sampling coupled with
molecular diagnosis in other epidemiological settings
to ratify the ‘ﬁt for purpose’ of this approach to point
of care diagnosis of CL.
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